EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Trypan blue teratogenesis in the rat: Further observations in vitro

Amir P. Gulamhusein, Weiland J. Moore, Madhu Gupta, Felix Beck

Teratology · 1982-12 · 26 (3) · 289-297

DOI: 10.1002/tera.1420260311 ↗
AbstractBibliografische Angaben

Abstract

Abstract Explanted 9½‐ and 10½‐day rat conceptuses were cultured for 24 or 48 hours and 24 hours respectively in immediately centrifuged, heat‐inactivated rat serum to which trypan blue was added at concentration of 150 μg/ml or 300 μg/ml or 450 μg/ml. The embryos were assessed for normal growth and differentiation using the following criteria: heart beat, vitelline circulation, fusion of the allantois with the chorion, normal turning, normally closed neural tube, presence of optic vesicles, presence of forelimb buds, tail, somites, somite number, yolk sac diameter, crown‐rump length, and protein content. The results indicated that trypan blue is more teratogenic when 9½‐day conceptuses are cultured for the first 24 hours, and that its teratogenicity decreases after 10½ days. Morphological abnormalities produced included neural tube defects, turning defects, and tail defects, the tail abnormalities being manifest as fluid‐filled blebs. Ten and one‐half–day conceptuses cultured for 24 hours in treated serum produced predominantly tail defects. The conceptuses were cultured at 11 days, when the embryo lies completely within the yolk sac. Culture of such conceptuses in serum containing 450 μg/ml trypan blue produced mainly tail defects. Injection of 0.5 μl of 0.5% dye solution into the yolk sac cavity also produced tail abnormalities; sham treatment, or the injection of sterile water or a nonteratogenic dye, azo blue, did not affect embryonic development.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →